0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587. FREE

Chaitanya R. Acharya, MS; David S. Hsu, MD, PhD; Carey K. Anders, MD; Ariel Anguiano, MD; Kelly H. Salter, BS; Kelli S. Walters, BS; Richard C. Redman, MD; Sascha A. Tuchman, MD; Cynthia A. Moylan, MD; Sayan Mukherjee, PhD; William T. Barry, PhD; Holly K. Dressman, PhD; Geoffrey S. Ginsburg, MD, PhD; Kelly P. Marcom, MD; Katherine S. Garman, MD; Gary H. Lyman, MD; Joseph R. Nevins, PhD; Anil Potti, MD
[+] Author Affiliations

Author Affiliations: Computational Biology and Bioinformatics (Mr Acharya) and Department of Statistical Sciences (Dr Mukherjee), Duke University, Durham, North Carolina; Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina (Drs Mukherjee, Dressman, Ginsburg, Garman, and Nevins) (j.nevins@duke.edu); Departments of Medicine (Drs Hsu, Marcom, Ginsburg, and Garman) and Biostatistics and Bioinformatics (Dr Barry), Hematology-Oncology Associates (Dr Tuchman), and Durham Veterans Affairs Medical Center (Dr Moylan), Duke University Medical Center, Durham, North Carolina; University of North Carolina Lineberger Cancer Center, Chapel Hill (Dr Anders); DCH Cancer Center, Medical Oncology, Tuscaloosa, Alabama (Dr Anguiano); University of North Carolina, Chapel Hill (Ms Salter); Department of Toxicology, North Carolina State University, Raleigh (Ms Walters); Pulmonary and Critical Care Medicine, South Sound Pulmonary Associates, Olympia, Washington (Dr Redman); Department of Medicine, Duke University School of Medicine, Duke Cancer Institute, Durham, North Carolina (Dr Lyman); and Coastal Cancer Center, Myrtle Beach, South Carolina (Dr Potti).


Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

More Author Information
JAMA. 2012;307(5):453. doi:10.1001/jama.2012.2.
Text Size: A A A
Published online

To the Editor: We would like to retract the article entitled “Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer,” which was published in the April 2, 2008, issue of JAMA.1 A component of this article reported the use of chemotherapy sensitivity predictions based on an approach described by Potti et al in Nature Medicine in 2006. The Nature Medicine article was recently retracted due to an inability to reproduce the results with the chemotherapy signatures.2 Because a significant component of this JAMA article was based on the use of chemotherapy signatures reported in the Nature Medicine paper, we have decided to retract the JAMA article. We apologize for any negative impact on scientific research or clinical care caused by the publication of our article in JAMA.

ARTICLE INFORMATION

Published Online: January 6, 2012. doi:10.1001/jama.2012.2.

REFERENCES

Acharya CR, Hsu DS, Anders CK,  et al.  Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.  JAMA. 2008;299(13):1574-1587
PubMed   |  Link to Article
Potti A, Dressman HK, Bild A,  et al.  Retraction: Genomic signatures to guide the use of chemotherapeutics.  Nat Med. 2011;17(1):135
PubMed   |  Link to Article

Figures

Tables

References

Acharya CR, Hsu DS, Anders CK,  et al.  Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.  JAMA. 2008;299(13):1574-1587
PubMed   |  Link to Article
Potti A, Dressman HK, Bild A,  et al.  Retraction: Genomic signatures to guide the use of chemotherapeutics.  Nat Med. 2011;17(1):135
PubMed   |  Link to Article
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...